These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34800094)

  • 1. Chemotherapy Extravasation: Incidence of and Factors Associated With Events in a Community Cancer Center.
    Ehmke N
    Clin J Oncol Nurs; 2021 Dec; 25(6):680-686. PubMed ID: 34800094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers.
    Jackson-Rose J; Del Monte J; Groman A; Dial LS; Atwell L; Graham J; O'Neil Semler R; O'Sullivan M; Truini-Pittman L; Cunningham TA; Roman-Fischetti L; Costantinou E; Rimkus C; Banavage AJ; Dietz B; Colussi CJ; Catania K; Wasko M; Schreffler KA; West C; Siefert ML; Rice RD
    Clin J Oncol Nurs; 2017 Aug; 21(4):438-445. PubMed ID: 28738039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
    Sauerland C; Engelking C; Wickham R; Corbi D
    Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing and managing vesicant chemotherapy extravasations.
    Schulmeister L
    J Support Oncol; 2010; 8(5):212-5. PubMed ID: 21086879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing vesicant extravasations.
    Schulmeister L
    Oncologist; 2008 Mar; 13(3):284-8. PubMed ID: 18378538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Oncology Nursing Society extravasation guidelines.
    Wengström Y; Margulies A;
    Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy extravasation from implanted ports.
    Schulmeister L; Camp-Sorrell D
    Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes: vesicants, irritants, or just irritating?
    Barbee MS; Owonikoko TK; Harvey RD
    Ther Adv Med Oncol; 2014 Jan; 6(1):16-20. PubMed ID: 24381657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extravasation of cytostatic agents: a serious complication of oncological treatment].
    Alfaro-Rubio A; Sanmartín O; Requena C; Llombart B; Botella-Estrada R; Nagore E; Serra-Guillén C; Hueso L; Guillén C
    Actas Dermosifiliogr; 2006 Apr; 97(3):169-76. PubMed ID: 16796963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk management of extravasation of cytostatic drugs at the Adult Chemotherapy Outpatient Clinic of a university hospital.
    Adami NP; de Gutiérrez MG; da Fonseca SM; de Almeida EP
    J Clin Nurs; 2005 Aug; 14(7):876-82. PubMed ID: 16000102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic.
    Sakaida E; Sekine I; Iwasawa S; Kurimoto R; Uehara T; Ooka Y; Akanuma N; Tada Y; Imai C; Oku T; Takiguchi Y
    Jpn J Clin Oncol; 2014 Feb; 44(2):168-71. PubMed ID: 24302758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for Management of Noncytotoxic Vesicant Extravasations.
    Ong J; Van Gerpen R
    J Infus Nurs; 2020; 43(6):319-343. PubMed ID: 33141794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IV vesicants: how to avoid extravasation.
    Wood LS; Gullo SM
    Am J Nurs; 1993 Apr; 93(4):42-6. PubMed ID: 8480802
    [No Abstract]   [Full Text] [Related]  

  • 14. Eliminating Extravasation Events: A Multidisciplinary Approach.
    Coyle CE; Griffie J; Czaplewski LM
    J Infus Nurs; 2015; 38 Suppl 6():S43-50. PubMed ID: 26536412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliminating extravasation events: a multidisciplinary approach.
    Coyle CE; Griffie J; Czaplewski LM
    J Infus Nurs; 2014; 37(3):157-64. PubMed ID: 24694509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicant extravasation: myths and realities.
    Boyle DM; Engelking C
    Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extravasation of Noncytotoxic Agents: Skin Injury and Risk Classification.
    Shibata Y; Taogoshi T; Matsuo H
    Biol Pharm Bull; 2023; 46(6):746-755. PubMed ID: 37258139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicant extravasation part II: Evidence-based management and continuing controversies.
    Wickham R; Engelking C; Sauerland C; Corbi D
    Oncol Nurs Forum; 2006 Nov; 33(6):1143-50. PubMed ID: 17149397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between subcutaneous steroid injection for extravasation of vesicant anticancer drugs and skin ulcers requiring surgery.
    Ohisa K; Yamana H; Morita K; Matsui H; Fushimi K; Yasunaga H
    Eur J Oncol Nurs; 2022 Jun; 58():102119. PubMed ID: 35358899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and treatment of chemotherapy extravasation injuries.
    Kassner E
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):135-48. PubMed ID: 10944862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.